Ceritinib Nitroso Impurity 2
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Ceritinib is used to treat metastatic (cancer that has already spread) non-small cell lung cancer in patients who have a certain type of abnormal anaplastic lymphoma kinase (ALK) gene. Your doctor will test for the presence of this gene. Ceritinib is an antineoplastic (cancer) agent.Ceritinib Nitroso Impurity 2 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Ceritinib Nitroso Impurity 2 CAS NO:NA chemically represented as N-(5-Chloro-4-((2-(isopropylsulfonyl)phenyl)amino)pyrimidin-2-yl)-N-(2-isopropoxy-5-methyl-4-(piperidin-4-yl)phenyl)nitrous amide. Synchemia is the leading manufacturing and exporter of Ceritinib Nitroso Impurity 2 . We supply Ceritinib Nitroso Impurity 2 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0141939 |
| CAS No | NA |
| Mol.F. | C19H20N6O3 |
| Mol.Wt. | 380.4 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141940 |
| CAS No | NA |
| Mol.F. | C26H32N6O5 |
| Mol.Wt. | 508.6 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141941 |
| CAS No | NA |
| Mol.F. | C29H30N8O6 |
| Mol.Wt. | 586.6 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141942 |
| CAS No | NA |
| Mol.F. | C30H32N8O6 |
| Mol.Wt. | 600.6 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141943 |
| CAS No | NA |
| Mol.F. | C17H19N5O4 |
| Mol.Wt. | 357.4 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141944 |
| CAS No | NA |
| Mol.F. | C8H9N3O3 |
| Mol.Wt. | 195.2 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141945 |
| CAS No | NA |
| Mol.F. | C8H7N3O5 |
| Mol.Wt. | 225.2 g/mol |
| INV STATUS | In Stock |
| CAT No | SRC-N0141946 |
| CAS No | NA |
| Mol.F. | C27H26N8O6 |
| Mol.Wt. | 558.6 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141947 |
| CAS No | NA |
| Mol.F. | C29H31N7O5 |
| Mol.Wt. | 557.6 g/mol |
| INV STATUS | In Stock |
| CAT No | SRC-N0141948 |
| CAS No | NA |
| Mol.F. | C27H27N7O5 |
| Mol.Wt. | 529.6 g/mol |
| INV STATUS | In Stock |
| CAT No | SRC-N0141949 |
| CAS No | NA |
| Mol.F. | C27H27N7O5 |
| Mol.Wt. | 529.6 g/mol |
| INV STATUS | In Stock |
| CAT No | SRC-N0141950 |
| CAS No | NA |
| Mol.F. | C27H28N8O4 |
| Mol.Wt. | 528.6 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141951 |
| CAS No | NA |
| Mol.F. | C20H20F2N4O7 |
| Mol.Wt. | 466.4 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141952 |
| CAS No | NA |
| Mol.F. | C20H20F2N4O7 |
| Mol.Wt. | 466.4 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141953 |
| CAS No | NA |
| Mol.F. | C24H30N2O4 |
| Mol.Wt. | 410.5 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141954 |
| CAS No | NA |
| Mol.F. | C13H18N6O2 |
| Mol.Wt. | 290.3 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |